Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Head and Neck Cancers
•
Radiation Oncology
•
Medical Oncology
How would you approach new dermal mets in a patient who recently finished chemoradiation for head and neck SCC?
Answer from: Radiation Oncologist at Academic Institution
Dermal mets are M1 disease. Since the patient received chemo, (s)he has a medical oncologist who should manage the case moving forward.
Sign in or Register to read more
Answer from: Radiation Oncologist at Academic Institution
Palliative systemic therapy or supportive care.
Sign in or Register to read more
18773
18774
Related Questions
How do you approach patients with node positive sebaceous cell carcinoma of the eyelid for adjuvant chemotherapy and radiation?
What is your approach to counseling patients who require definitive radiation therapy to the head and neck but for whatever reason, cannot/will not undergo recommended extractions?
What are best practices for oncologists during the national platinum shortage?
How do you consider the role of probiotics for mucositis mitigation in patients receiving head and neck radiotherapy?
What are magic mouthwash alternatives that you would recommend?
In a patient with history of successfully treated locally advanced H&N cancer, how do you discern between a metachronous second primary locally advanced lung SCC vs. metastatic head and neck SCC?
In what clinical situations do you order NavDx?
How do you counsel patients and partners of patients with HPV+ cancers regarding the HPV vaccine?
What is your approach to treat metastatic poorly differentiated thyroid cancer with papillary features?
In patients with nasopharyngeal SCC that have an excellent response to induction chemo, do you alter your chemo-RT dose/volumes in any way?